DNA damage response as a biomarker in treatment of leukemias

Early assessment of cancer response to the treatment is of great importance in clinical oncology. Most antitumor drugs, among them DNA topoisomerase (topo) inhibitors, target nuclear DNA. The aim of the present study was to explore feasibility of the assessment of DNA damage response (DDR) as potent...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Asıl Yazarlar: Halicka, H. Dorota, Ozkaynak, M. Fevzi, Levendoglu-Tugal, Oya, Sandoval, Claudio, Seiter, Karen, Kajstura, Malgorzata, Traganos, Frank, Jayabose, Somasunadaram, Darzynkiewicz, Zbigniew
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: 2009
Konular:
Article
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC3863585/
https://ncbi.nlm.nih.gov/pubmed/19411853
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller